MA52877A - Acide hyaluronique stabilisé - Google Patents

Acide hyaluronique stabilisé

Info

Publication number
MA52877A
MA52877A MA052877A MA52877A MA52877A MA 52877 A MA52877 A MA 52877A MA 052877 A MA052877 A MA 052877A MA 52877 A MA52877 A MA 52877A MA 52877 A MA52877 A MA 52877A
Authority
MA
Morocco
Prior art keywords
hyaluronic acid
stabilized hyaluronic
stabilized
acid
hyaluronic
Prior art date
Application number
MA052877A
Other languages
English (en)
Inventor
Robert Sachsenhofer
Original Assignee
Croma Pharma Ges M B H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croma Pharma Ges M B H filed Critical Croma Pharma Ges M B H
Publication of MA52877A publication Critical patent/MA52877A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
MA052877A 2018-06-15 2019-06-14 Acide hyaluronique stabilisé MA52877A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18178099 2018-06-15
EP18178098 2018-06-15
EP18178097 2018-06-15

Publications (1)

Publication Number Publication Date
MA52877A true MA52877A (fr) 2021-04-21

Family

ID=66821271

Family Applications (2)

Application Number Title Priority Date Filing Date
MA052877A MA52877A (fr) 2018-06-15 2019-06-14 Acide hyaluronique stabilisé
MA052880A MA52880A (fr) 2018-06-15 2019-06-14 Composition d'hydrogel comprenant un polymère réticulé

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA052880A MA52880A (fr) 2018-06-15 2019-06-14 Composition d'hydrogel comprenant un polymère réticulé

Country Status (13)

Country Link
US (2) US12097277B2 (fr)
EP (2) EP3806918A1 (fr)
JP (2) JP7374133B2 (fr)
KR (2) KR20210021362A (fr)
CN (3) CN112334165A (fr)
BR (2) BR112020024735B1 (fr)
CA (2) CA3101412A1 (fr)
ES (1) ES2983810T3 (fr)
IL (2) IL279445B2 (fr)
MA (2) MA52877A (fr)
MX (1) MX2020013000A (fr)
PL (1) PL3806919T3 (fr)
WO (2) WO2019238954A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3061777T3 (en) 2018-06-15 2026-04-07 Croma Pharma Gmbh Hydrogel composition comprising a crosslinked polymer
WO2019238954A1 (fr) 2018-06-15 2019-12-19 Croma-Pharma Gmbh Composition d'hydrogel comprenant un polymère réticulé
EP4077402B1 (fr) 2019-12-19 2024-05-01 Croma-Pharma GmbH Hyaluronane modifié par thiol et hydrogel comprenant l'hyaluronane réticulé
EP4090317A4 (fr) * 2020-01-16 2024-02-21 The Hong Kong University of Science and Technology Compositions et procédés pour la libération contrôlée d'un agent cible
CN115702937B (zh) * 2021-08-04 2024-12-17 四川大学 改性多酚载体材料、靶向纳米递送系统及制备方法和用途
KR20230145624A (ko) * 2022-04-08 2023-10-18 (주)아크로스 안전성이 우수한 조직수복용 생체재료의 제조 방법
CN115414276A (zh) * 2022-06-24 2022-12-02 辽宁德玛生物科技有限公司 一种注射用琼脂糖凝胶剂及其制备方法
TWI840941B (zh) * 2022-09-06 2024-05-01 科妍生物科技股份有限公司 製造自體交聯透明質酸凝膠之方法及其產物
IT202200023682A1 (it) 2022-11-16 2024-05-16 Francesco Bernardini Composizioni e metodi per migliorare difetti volumetrici del viso
WO2024113006A1 (fr) * 2022-11-28 2024-06-06 Telethon Kids Institute Nouveaux hydrogels
CN117298355B (zh) * 2023-11-28 2024-03-08 常州百瑞吉生物医药股份有限公司 一种包裹性透明质酸凝胶组合物及其制备方法与应用
CN121695258A (zh) * 2026-02-10 2026-03-20 常州百瑞吉生物医药股份有限公司 无色透明的重组人源化胶原蛋白-巯基化透明质酸复合水凝胶及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
AT406054B (de) 1998-11-04 2000-02-25 Andreas Bernkop-Schnuerch Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
CA2416126C (fr) 2000-07-28 2011-07-05 Anika Therapeutics, Inc. Composites bioabsorbables d'acide hyaluronique derive
WO2002056914A1 (fr) 2001-01-19 2002-07-25 Hironori Yamamoto Injections destinees a une endoscopie
ATE312076T1 (de) 2001-02-22 2005-12-15 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
GB2386900B (en) 2002-03-25 2006-11-01 Johnson & Johnson Medical Ltd Use in wound dressings of chemically modified polysaccharides
EP1539799B1 (fr) 2002-06-21 2013-12-11 The University of Utah Research Foundation Composés reticulés et leurs procédés de préparation et d'utilisation
EP1694712A1 (fr) 2003-12-04 2006-08-30 University of Utah Research Foundation Macromolecules modifiees et procedes de production et d'utilisation associes
EP1710257A4 (fr) 2004-01-07 2011-03-23 Seikagaku Kogyo Co Ltd Derive d'acide hyaluronique et medicament contenant ce dernier
US7807675B2 (en) 2004-04-02 2010-10-05 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid-methotrexate conjugate
US8143391B2 (en) 2004-09-07 2012-03-27 Chugai Seiyaku Kabushiki Kaisha Process for producing water-soluble hyaluronic acid modification
ITPD20050242A1 (it) 2005-08-03 2007-02-04 Fidia Farmaceutici Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico
EA013877B1 (ru) 2005-09-07 2010-08-30 Алкемиа Онколоджи Пти Лимитед Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
CN101511875A (zh) 2006-07-11 2009-08-19 犹他大学研究基金会 硫醇化的大分子及其制备方法和应用
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
CN101200504B (zh) 2006-12-11 2010-05-12 上海百瑞吉生物医药有限公司 高分子巯基化改性衍生物及其交联材料
RU2432181C2 (ru) 2006-12-22 2011-10-27 Кромафарма Гезельшафт М.Б.Х. Применение полимеров
EP2155212A2 (fr) * 2007-05-11 2010-02-24 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008148071A2 (fr) 2007-05-24 2008-12-04 Nidus2, Llc Derme injectable
WO2009005790A2 (fr) 2007-06-29 2009-01-08 Carbylan Biosurgery, Inc. Compositions stériles de polymère d'acide hyaluronique et procédés correspondants
US20110038939A1 (en) * 2007-07-16 2011-02-17 Northeastern University Therapeutic stable nanoparticles
US9161970B2 (en) * 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
EP2254610A4 (fr) 2008-02-22 2013-07-31 Dermal Technologies Llc Compositions pour augmentation de tissus
WO2009108100A1 (fr) 2008-02-29 2009-09-03 Ipr-Systems Sweden Ab Composition pour la formation de gels
EP2313104B2 (fr) 2008-04-24 2020-08-26 Medtronic, Inc Gel de chitosane thiolé
CN101367884A (zh) 2008-09-25 2009-02-18 复旦大学 一种半胱胺修饰的巯基化透明质酸偶合物及其制备方法和应用
CN101721349B (zh) * 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
WO2010111161A2 (fr) 2009-03-23 2010-09-30 Genzyme Corporation Réparation de cartilage
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CN102399295B (zh) 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
US9393263B2 (en) * 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
AU2012308503B2 (en) * 2011-09-14 2015-08-13 Allergan Industrie, Sas Dermal filler compositions for fine line treatment
PL3175840T3 (pl) 2011-12-08 2021-01-25 Allergan Industrie, Sas Kompozycje wypełniacza skórnego
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
ES2661913T3 (es) 2013-05-08 2018-04-04 Allergan Industrie Geles de ácido hialurónico reticulados con trimetafosfato de sodio
MX369409B (es) * 2013-06-28 2019-11-07 Galderma Sa Método para la fabricación de un producto perfilado de ácido hialurónico.
ITMI20131193A1 (it) 2013-07-16 2015-01-17 Ira Srl Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico
EP3166652B1 (fr) 2014-07-11 2019-04-03 Allergan Industrie, SAS Gels d'acide hyaluronique réticulés par du trimétaphosphate de sodium
CN104892962B (zh) * 2015-06-05 2017-12-08 四川大学 一种巯基/二硫键可控自交联透明质酸水凝胶的制备方法及其应用
IT201600096125A1 (it) 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
AR110125A1 (es) 2016-11-07 2019-02-27 Croma Pharma Ges M B H Compuestos poliméricos que liberan sulfuro de hidrógeno
CN108465128B (zh) 2018-03-01 2021-03-16 杭州协合医疗用品有限公司 一种交联透明质酸细胞支架材料的制备方法
WO2019238954A1 (fr) 2018-06-15 2019-12-19 Croma-Pharma Gmbh Composition d'hydrogel comprenant un polymère réticulé

Also Published As

Publication number Publication date
CA3101410A1 (fr) 2019-12-19
IL279446A (en) 2021-01-31
CN112334165A (zh) 2021-02-05
IL279445B2 (en) 2025-05-01
BR112020024637A2 (pt) 2021-03-02
EP3806919B1 (fr) 2024-05-15
BR112020024735A2 (pt) 2021-03-23
MX2020013000A (es) 2021-03-29
MA52880A (fr) 2021-09-22
IL279445B1 (en) 2025-01-01
IL279445A (en) 2021-01-31
EP3806918A1 (fr) 2021-04-21
CA3101412A1 (fr) 2019-12-19
WO2019238955A1 (fr) 2019-12-19
KR20210021362A (ko) 2021-02-25
US12458582B2 (en) 2025-11-04
JP2021526933A (ja) 2021-10-11
BR112020024637B1 (pt) 2024-01-30
PL3806919T3 (pl) 2024-10-28
JP2021526934A (ja) 2021-10-11
JP7374133B2 (ja) 2023-11-06
KR102852956B1 (ko) 2025-09-03
IL279446B1 (en) 2025-01-01
US20210259943A1 (en) 2021-08-26
KR20210021363A (ko) 2021-02-25
ES2983810T3 (es) 2024-10-24
EP3806919A1 (fr) 2021-04-21
CN116650519A (zh) 2023-08-29
US12097277B2 (en) 2024-09-24
WO2019238954A1 (fr) 2019-12-19
US20210260243A1 (en) 2021-08-26
BR112020024735B1 (pt) 2024-02-27
IL279446B2 (en) 2025-05-01
CN112334167A (zh) 2021-02-05

Similar Documents

Publication Publication Date Title
MA52877A (fr) Acide hyaluronique stabilisé
DK3767753T3 (da) Konnektor
EP4023176C0 (fr) Stabilisateur
EP4019200A4 (fr) Système de production
DK4177504T3 (da) Forbindelse
MA42615A (fr) Composés phosphodiamide antiviraux d'ester d'acide bêta-aminé
EP3808783A4 (fr) Nouvel acide alginique réticulé
DK3767754T3 (da) Konnektor
HUE055703T2 (hu) Eljárás hialuronsav tisztítására
EP3541297A4 (fr) Stylets d'intubation
EP3587576A4 (fr) Acide oligonucléique anti-sens
EP3818281A4 (fr) Connecteur structurel
DK3807497T3 (da) Pumpesystem
EP3989373A4 (fr) Connecteur
EP3600279A4 (fr) Formulations d'acide 1-amino-1-cyclopropanecaboxylique
EP3475069C0 (fr) Système de pultrusion
EP3986832A4 (fr) Nanocomposites de polymère de polyester
EP3795273C0 (fr) Moule
EP4036449C0 (fr) Joint fileté
PL3755363T3 (pl) Warianty plantarycyny nc8alfabeta
EP3768623A4 (fr) Ensemble d'alignement
EP3764818A4 (fr) Orienteur de production
EP3664231A4 (fr) Système d'amplification optique
EP3573187C0 (fr) Dispositif connecteur enfichable
EP3803183C0 (fr) Raccord rapide